It can take as little as five minutes online to get a prescription for a GLP-1 drug for weight loss. That fast access has drawn increasing scrutiny from medical experts.
These medications, such as Ozempic and Wegovy, require careful medical evaluation. Yet some telehealth companies bypass standard safety protocols to speed up the process.
New research suggests these firms prioritize quick prescriptions over comprehensive patient care. The findings raise concerns about misdiagnosis and overlooked side effects.
A rapid consultation may not include a full medical history review. Doctors need to screen for thyroid conditions, pancreatitis, and other risk factors before prescribing.
Many patients using these services receive incorrect dosages or fail to get proper follow-up care. This can lead to serious health complications over time.
The Food and Drug Administration has not approved these drugs for weight loss without a full medical assessment. Experts warn that the online model may undermine that standard.
Patients should seek evaluations from their regular doctors instead. Thorough medical oversight remains critical when using powerful weight loss medications.
